European Companies Search Engine
MD: Klaus Menken, Stefan Oelrich, Sabine Radl · PPA (9) · Control: Sanofi-Aventis Deutschland GmbH · Control: Sanofi-Aventis Deutschland GmbH · Change of headquarters · Address · Capital: €600,000 Hrb14 Jan 2013 German Trade Register Announcements, Germany (10/01/2013)
Overview
Text
Winthrop Arzneimittel GmbH, Frankfurt am Main, Brüningstr. 50, 65926 Frankfurt am Main. GmbH. Partnership agreement of May 8, 1996, amended several times. The Shareholders' Meeting of December 7, 2012 approved the amendment of the partnership agreement in Section 2 (seat) and with it the; Seat transfer from Mülheim-Kärlich (previously District Court of Koblenz HRB 14056) to Frankfurt am Main. Business address: Brüningstr. 50, 65926 Frankfurt am Main. The aim is to manufacture, market and distribute pharmaceutical and cosmetic and similar preparations and products and foodstuffs and related services, as well as to pharmaceutical wholesalers, together with the import and export of these articles and the exercise of all related transactions. Share capital: EUR 600,000.00. General; Representation regulation: If only one managing director is appointed, he shall represent the company alone. If several directors are appointed, the company is represented by two directors or by a managing director together with an authorized representative. Managing Director: Dr. Menken, Klaus, Königstein im Taunus, *??.??.????; Oelrich, Stefan, Berlin, *??.??.????. Managing Director: Radl, Sabine, Berlin, *??.??.????. Gesamtprokura together with a managing director or another authorized representative: ??????, ???? ??, Niedernhausen, *??.??.????; ??????, ??????, Niedernhausen, *??.??.????; ????????, ??????, Hofheim am Taunus, *??.??.????; ?????, ???????, Fürstenfeldbruck, *??.??.????; ????, ???????, Kleinmachnow, *??.??.????; ?????, ????????, Berlin, *??.??.????; ???????, ???????, Berlin, *??.??.????; ????????, ????, Berlin, *??.??.????; ??????, ????, Gersthofen, *??.??.????. With the Sanofi-Aventis Deutschland GmbH based in Frankfurt am Main (District Court of Frankfurt HRB 40661) as the dominant company, a profit transfer agreement was concluded on June 14, 2007. It was approved by the Shareholders' Meeting of June 19, 2007. The profit and result transfer agreement is amended by contract of December 11, 2009, which was approved by the Shareholders' Meeting on December 11, 2009. With the Sanofi-Aventis Deutschland GmbH based in Frankfurt am Main (District Court of Frankfurt HRB 40661) a.s. the dominant company, a control and management contract was concluded on 09. / March 16, 2009. The shareholders' meeting of March 16, 2009 approved it. The control and management agreement is amended by contracts of December 10, 2010 and December 20, 2011, which were approved by the Shareholders' Meeting of December 10, 2010 and December 20, 2011.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Zentiva Pharma GmbH, Frankfurt a. Main, Germany.
The visualizations for "Winthrop Arzneimittel GmbH - Managing Director: Klaus Menken, Stefan Oelrich, Sabine Radl · Officer (9) · Control: Sanofi-Aventis Deutschland GmbH · Control: Sanofi-Aventis Deutschland GmbH · Change of headquarters · Address · Capital: €600,000 · Shareholder agreement · Proxy · Corporate Purpose"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
